| Literature DB >> 23627825 |
Zhengqing Hu1, Mats Ulfendahl.
Abstract
Hearing loss is one of the most common disabilities, affecting approximately 10% of the population. Hair cells and spiral ganglion neurons are usually damaged in most cases of hearing loss. Currently, there is virtually no biological approach to replace damaged hearing cells. Recent developments in stem cell technology provide new opportunities for the treatment of deafness. Two major strategies have been investigated: differentiation of endogenous stem cells into new hair cells; and introduction of exogenous cells into the inner ear to substitute injured hearing neurons. Although there is still a learning curve in stem cell-based replacement, the probability exists to utilize personalized stem cells to eventually provide a novel intervention for patients with deafness in future clinical research trials.Entities:
Mesh:
Year: 2013 PMID: 23627825 PMCID: PMC3802542 DOI: 10.2217/rme.13.32
Source DB: PubMed Journal: Regen Med ISSN: 1746-0751 Impact factor: 3.806